Casirivimab and imdevimab as investigational monoclonal antibodies for COVID-19 patients – review of the literature
Language: English
Page range: 138 - 141
Submitted on: Mar 29, 2021
Accepted on: Aug 20, 2021
Published online: Oct 8, 2021
Published in print: Sep 1, 2021
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2021 Gabriela Reka, Angelika Pawlak, Piotr Machowiec, Marcela Maksymowicz, Halina Piecewicz-Szczesna, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.